Pluri (PLUR) Long-Term Deferred Tax (2014 - 2025)
Pluri (PLUR) posted quarterly Long-Term Deferred Tax of $69.6 million for Q2 2025, little changed year-over-year from $69.9 million in Q2 2024, and little changed quarter-over-quarter from $69.9 million in Q2 2024.
Pluri (PLUR) Long-Term Deferred Tax (2014 - 2025) Analysis & Trends
Pluri (PLUR) has reported Long-Term Deferred Tax for 6 consecutive years, with $69.6 million the latest figure, recorded in Q2 2025.
- In Q2 2025, Long-Term Deferred Tax changed 0.42% year-over-year to $69.6 million; the TTM figure through Jun 2025 stood at $69.6 million (changed 0.42% YoY), while the FY2025 annual figure was $69.6 million, changed 0.42% from the prior year.
- Long-Term Deferred Tax steadied at $69.6 million in Q2 2025 per PLUR's latest filing, from $69.9 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $80.5 million in Q2 2023 and bottomed at $65.4 million in Q2 2022.
- Historically, Long-Term Deferred Tax has averaged $71.3 million across 4 years, with a median of $69.7 million in 2024.
- Annual changes were most pronounced in 2023 — Long-Term Deferred Tax climbed 23.17% — and 2024, when it dropped 13.26%.
- Pluri's Long-Term Deferred Tax stood at $65.4 million in 2022, then increased by 23.17% to $80.5 million in 2023, then fell by 13.26% to $69.9 million in 2024, then dropped by 0.42% to $69.6 million in 2025.
- Business Quant data shows PLUR's Long-Term Deferred Tax at $69.6 million in Q2 2025, $69.9 million in Q2 2024, and $80.5 million in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 69.56 Mn |
| Jun 30, 2024 | 69.85 Mn |
| Jun 30, 2023 | 80.53 Mn |
| Jun 30, 2022 | 65.38 Mn |
| Jun 30, 2015 | 29.24 Mn |
| Jun 30, 2014 | 21.00 Mn |